Podchaser Logo
Home
Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Released Tuesday, 8th November 2022
Good episode? Give it some love!
Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Episode 377: American Academy of Ophthalmology 2022 Meeting Retina Recap

Tuesday, 8th November 2022
Good episode? Give it some love!
Rate Episode

Drs. Avni Finn and Shriji Patel join to discuss big takeaways from the 2022 AAO Annual Meeting, including discussion of biosimilars, dry AMD treatments, high-dose aflibercept, and private equity influence in the retina community.


Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Allergan, Apellis, DORC, Genentech, Ocuterra, and Regeneron. Dr. Finn is a consultant for Allergan and Genentech. Dr. Patel has no relevant disclosures.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features